On drug marketing meet new fierce battle.docVIP

 PAGE \* MERGEFORMAT 11 On drug marketing meet new fierce battle ‘This year the change is too big, bad do marketing now companies have to consider is what kind of come up with next year the new things.’ Continuous multi-day conference that CONBA Group within the company’s chief advisor wish Peter good tired , ‘Why do bad - we all know.’ sounds like a slogan, but I wish Peter good tone but not the slightest joke means, but full of heavy and helpless. ‘Now we are asked to meet, how this kind of results are the same facial expressions: smile after that is shaking his head.’ Shanghai Fuxing Pharmaceutical Group Co., Ltd. Assistant to the President Tao Zhaohui said. This year’s winter was a mild winter. But the opposite is the climate and the natural world, this year in the eyes of drug marketing is an unprecedented ‘winter.’ Policy of the pain ‘I feel that 2006 was the year of the pharmaceutical industry’s most oscillation.’ Pharmaceutical Co., Ltd. Beijing Branch Ring Wang Heng, vice president of marketing, said. This is not without reason. Official figures show first half of 2006, the pharmaceutical industry’s profit growth has dropped to historic lows, the direct reason is that the policies introduced this year. Following medical treatment is difficult and expensive to become this year’s ‘two sessions’ after one of the most popular topic as soon as possible to resolve this issue has become the common voice of the entire society from top to bottom, on March 15, the State Food and Drug Administration issued a new revised lt;lt;package insert and labeling requirementsgt;gt; (24 orders of generic drugs, trade names and trademarks are used to make a strict limit. Then, eight ministries and commissions jointly combat bribery in business, June 29, the Tenth NPC Standing Committee of the 22nd meeting a formal vote by the Criminal Law Amendment (6, the original Article 163 of the Criminal Code, companies, business people su